Pioneering innovative new treatments for patients with neurological diseases​

Learn More about OUR Pipeline

Targeting the metabolic basis of diseases of the brain​

Learn More about OUR Science

A world-class team of drug developers focused on addressing huge areas of unmet medical need

Learn More About OUR Technology

Unparalleled experience and knowledge in complex formulations and lipid-drug development

Learn More about Us

Latest News

1 / 6

  • Cerecin Expands Leadership Team with Appointment of Chief Medical Officer and Chief Operating Officer

    01 September 2024
    View More

  • Cerecin Bolsters Pipeline with a Strategic Acquisition From Boston Scientific

    01 January 2024
    View More

  • Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders

    1 December 2023
    View More

  • Cerecin strengthens position in neurometabolism with addition to pipeline

    19 September 2023
    View More

  • Cerecin to Present New Infantile Spasms Data at the 35th Interna1onal Epilepsy Congress, Dublin 2023

    30 August 2023
    View More

  • Clinical Trial Data of Novel Metabolic Mechanism in Migraine: CER-0001, a Ketogenic Investigational Agent

    30 June 2023
    View More

Our Partners

en_USEnglish
ko_KRKorean en_USEnglish